Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-22-011570
Filing Date
2022-03-24
Accepted
2022-03-24 07:00:19
Documents
2
Period of Report
2022-03-24

Document Format Files

Seq Description Document Type Size
1 6-K frln-6k_20220324.htm 6-K 26099
2 EX-99.1 frln-ex991_6.htm EX-99.1 24661
  Complete submission text file 0001564590-22-011570.txt   51994
Mailing Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX
Business Address STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2FX 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Filer) CIK: 0001810031 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39431 | Film No.: 22764666
SIC: 2836 Biological Products, (No Diagnostic Substances)